Ligand validation:2YCX

SOG: octyl 1-thio-beta-D-glucopyranoside

SOG is a Ligand Of Interest in 2YCX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2YCX_SOG_B_1362	5%	34%	0.342	0.741	1.35	1.28	2	3	1	0	100%	1
2YCX_SOG_B_1361	3%	24%	0.277	0.61	1.43	1.66	3	6	3	0	100%	1
2YCX_SOG_B_1360	0%	24%	0.627	0.587	1.31	1.76	3	6	0	0	100%	1
2VT4_SOG_A_403	67%	60%	0.141	0.95	0.59	0.92	-	-	0	0	100%	1
2YCY_SOG_A_1360	22%	52%	0.303	0.923	0.63	1.2	-	2	3	0	100%	1
2YCZ_SOG_B_1360	2%	40%	0.43	0.672	1.25	1.08	2	2	0	0	100%	1
6TOS_SOG_B_406	70%	81%	0.109	0.927	0.31	0.51	-	-	0	0	100%	1
6YU6_SOG_A_507	64%	91%	0.138	0.937	0.18	0.39	-	-	3	0	100%	1
6TOT_SOG_A_405	55%	44%	0.159	0.929	0.91	1.24	1	1	0	0	100%	1
5G53_SOG_A_501	54%	39%	0.17	0.937	1.01	1.37	1	3	0	0	100%	1
3VHZ_SOG_A_430	53%	27%	0.144	0.906	1.73	1.21	5	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.